Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients

Pediatric Transplantation

Volumn 19, Issue 2, 2015, Pages 219-228

  Giaquinta, Sarah ^a   Michaels, Marian G ^b   McCullers, Jonathan A ^c,d   Wang, Li ^a   Fonnesbeck, Christopher ^a   O'Shea, Alice ^a   Green, Michael ^b   Halasa, Natasha B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

influenza; solid organ transplant; vaccine

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SCHOOL CHILD; SEROCONVERSION; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; GRAFT RECIPIENT; INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PRESCHOOL CHILD; SAMPLE SIZE; TREATMENT OUTCOME; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; ORGAN TRANSPLANTATION; PATIENT SAFETY; PROSPECTIVE STUDIES; SAMPLE SIZE; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME; VACCINATION;

EID: 84921598428     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12419     Document Type: Article

References (37)

1. Thompson WW, Shay DK, Weintraub E,. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003: 289: 179-186.
2. Apalsch AM, Green M, Ledesma-Medina J, Nour B, Wald ER,. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995: 20: 394-399.
3. Ison MG, Michaels MG,. RNA respiratory viral infections in solid organ transplant recipients. Am J Transplant 2009: 9: S166-S172.
4. Chon WJ, Kadambi PV, Harland RC, et al. Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol 2010: 5: 1637-1641.
5. Ison MG,. Antiviral therapies for respiratory viral infections in lung transplant patients. Antivir Ther 2012: 17 (1 Pt B): 193-200.
6. Ison MG, Hirsch HH,. Influenza: A recurrent challenge to transplantation. Transpl Infect Dis 2010: 12: 95-97.
7. Lopez-Medrano F, Aguado JM, Lizasoain M, et al. Clinical implications of respiratory virus infections in solid organ transplant recipients: A prospective study. Transplantation 2007: 84: 851-856.
8. Weinstock DM, Gubareva LV, Zuccotti G,. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003: 348: 867-868.
9. Ison MG, Hayden FG,. Viral infections in immunocompromised patients: What's new with respiratory viruses? Curr Opin Infect Dis 2002: 15: 355-367.
10. Briggs JD, Timbury MC, Paton AM, Bell PR,. Viral infection and renal transplant rejection. Br Med J 1972: 4: 520-522.
11. Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the organ transplant recipient: Review and summary recommendations. Am J Transplant 2011: 11: 2020-2030.
12. Nailescu C, Xu X, Zhou H, et al. Influenza vaccine after pediatric kidney transplant: A Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 2011: 26: 459-467.
13. Madan RP, Tan M, Fernandez-Sesma A, et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008: 46: 712-718.
14. Long CB, Ramos I, Rastogi D, et al. Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children. J Pediatr 2012: 160: 74-81.
15. Cordero E, Manuel O,. Influenza vaccination in solid-organ transplant recipients. Curr Opin Organ Transplant 2012: 17: 601-608.
16. Gotoh K, Ito Y, Suzuki E, et al. Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons. Pediatr Transplant 2011: 15: 112-116.
17. C enters for D isease C ontrol and P revention (CDC). Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use-United States. MMWR Morb Mortal Wkly Rep 2010: 59: 485-486.
18. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014: 371: 635-645.
19. A merican A cademy of P ediatrics C ommittee on I nfectious D iseases. Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics 2011: 128: 813-825.
20. McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N,. Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer 2014: 61: 815-820.
21. Keitel WA, Cate TR, Atmar RL, et al. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin Diagn Lab Immunol 1996: 3: 507-510.
22. Couch RB, Winokur P, Brady R, et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 2007: 25: 7656-7663.
23. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ,. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009: 200: 172-180.
24. WHO Expert Committee on biological standardization. World Health Organ Tech Rep Ser 2011: 963: 1-244.
25. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014: 58: e44-e100.
26. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002: 2: 287-291.
27. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: A multicentre cohort study. Lancet Infect Dis 2010: 10: 521-526.
28. Billings JL, Hertz MI, Savik K, Wendt CH,. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 2002: 21: 559-566.
29. Billings JL, Hertz MI, Wendt CH,. Community respiratory virus infections following lung transplantation. Transpl Infect Dis 2001: 3: 138-148.
30. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC,. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998: 17: 1075-1080.
31. Danziger-Isakov L, Cherkassky L, Siegel H, et al. Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation 2010: 89: 838-844.
32. Vermeiren P, Aubert V, Sugamele R, et al. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transpl Int 2014: 903-908.
33. Baluch A, Humar A, Eurich D, et al. Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. Am J Transplant 2013: 13: 1026-1033.
34. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009: 9: 2346-2354.
35. Zeman AM, Holmes TH, Stamatis S, et al. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr Infect Dis J 2007: 26: 107-115.
36. He XS, Holmes TH, Zhang C, et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006: 80: 11756-11766.
37. Pittet LF, Posfay-Barbe KM,. Immunization in transplantation: Review of the recent literature. Curr Opin Organ Transplant 2013: 19: Jul 4. [Epub ahead of print].